TABLE 4.
Predictor | High Dosage (n = 85,710) | P Value | Multiple Providers (n = 80,630) | P Value | Opioids + Benzodiazepine (n = 85,710) | P Value | |
---|---|---|---|---|---|---|---|
AOR (95% CI) | AOR (95% CI) | AOR (95% CI) | |||||
Age, years | 1.01 (1.01-1.02) | < 0.001 | 0.96 (0.95-0.96) | < 0.001 | 1.03 (1.03-1.03) | < 0.001 | |
Female | 0.63 (0.59-0.67) | < 0.001 | 0.95 (0.89-1.02) | 0.160 | 1.26 (1.22-1.31) | < 0.001 | |
Race (reference = white) | |||||||
Black | 0.84 (0.77-0.91) | < 0.001 | 1.53 (1.41-1.65) | < 0.001 | 0.70 (0.67-0.73) | < 0.001 | |
Hispanic | 0.46 (0.38-0.55) | < 0.001 | 0.85 (0.75-0.98) | 0.020 | 1.22 (1.15-1.30) | < 0.001 | |
Other | 0.87 (0.68-1.11) | 0.250 | 0.98 (0.77-1.25) | 0.890 | 0.84 (0.75-0.95) | 0.004 | |
Urban | 1.08 (0.99-1.19) | 0.090 | 1.38 (1.25-1.52) | < 0.001 | 1.15 (1.10-1.21) | < 0.001 | |
Eligibility (reference = nondisabled adults) | |||||||
Disabled | 1.18 (1.06-1.32) | 0.003 | 0.66 (0.60-0.73) | < 0.001 | 1.28 (1.21-1.35) | < 0.001 | |
Medicaid expansion | 0.91 (0.82-1.02) | 0.120 | 1.06 (0.97-1.16) | 0.210 | 0.94 (0.89-0.99) | 0.020 | |
Heroin/opioid overdose | 1.43 (1.10-1.85) | 0.010 | 1.05 (0.84-1.31) | 0.660 | 1.25 (1.08-1.45) | 0.003 | |
Opioid use disorder | 2.01 (1.83-2.21) | < 0.001 | 1.43 (1.31-1.57) | < 0.001 | 1.04 (0.98-1.10) | 0.180 | |
Anxiety disorder | 0.99 (0.92-1.07) | 0.770 | 1.54 (1.43-1.65) | < 0.001 | 3.50 (3.38-3.63) | < 0.001 | |
Mood disorder | 0.86 (0.79-0.93) | < 0.001 | 1.15 (1.06-1.25) | < 0.001 | 1.42 (1.36-1.48) | < 0.001 | |
Medication-assisted treatment | 0.83 (0.68-1.02) | 0.080 | 1.09 (0.93-1.27) | 0.280 | 1.22 (1.11-1.34) | < 0.001 | |
Antidepressant drug use | 0.94 (0.87-1.01) | 0.100 | 1.00 (0.93-1.08) | 0.990 | 1.53 (1.47-1.59) | < 0.001 | |
Opioid fills | 1.18 (1.18-1.19) | < 0.001 | 1.10 (1.09-1.10) | < 0.001 | 1.09 (1.09-1.10) | < 0.001 | |
Elixhauser Index | 0.91 (0.90-0.93) | < 0.001 | 1.15 (1.13-1.16) | < 0.001 | 0.97 (0.96-0.98) | < 0.001 |
AOR = adjusted odds ratio; CI = confidence interval.